---
title: Allopregnanolone in the pathogenesis of the psychiatric comorbidities of polycystic
  ovarian syndrome.
authors: '[''Karis ISarkisian'', ''Jane LYang'', ''ChristineMarshall'', ''Frank ZStanczyk'']'
journal: The Journal of steroid biochemistry and molecular biology
publication_date: ''
doi: 10.1016/j.jsbmb.2025.106719
pmid: ''
document_type: research_paper
source: PubMed
search_category: pmdd_mechanisms
search_query: PMDD pathophysiology
tags:
- pmdd
- clinical_research
- pathophysiology
- genetics
- premenstrual_dysphoric_disorder
- neuroimaging
- hormones_endocrine
created_date: '2025-10-21'
content_type: research_paper
condition: pmdd
topic: premenstrual_dysphoric_disorder
---

# Allopregnanolone in the pathogenesis of the psychiatric comorbidities of polycystic ovarian syndrome.

## Authors
['Karis ISarkisian', 'Jane LYang', 'ChristineMarshall', 'Frank ZStanczyk']

## Journal
The Journal of steroid biochemistry and molecular biology

## Publication Information
- **Year**: 
- **DOI**: 10.1016/j.jsbmb.2025.106719
- **PMID**: 

## Abstract
Polycystic ovarian syndrome (PCOS) is an endocrine disorder affecting 10-15 % of women of reproductive age, with significant implications for both physical and mental health. Several recent research studies have examined the connection between PCOS and psychiatric disorders; however, the mechanism linking the two is not fully understood. Allopregnanolone is a neurosteroid that modulates GABA

## Keywords
pmdd, clinical_research, pathophysiology, genetics, premenstrual_dysphoric_disorder, neuroimaging, hormones_endocrine

## Source Information
- **Source**: PubMed
- **Search Category**: pmdd_mechanisms
- **Search Query**: PMDD pathophysiology

---
*This document was automatically processed from PubMed and added to the PMDD research knowledge base.*
